ASP 2535

Modify Date: 2024-04-05 17:00:59

ASP 2535 Structure
ASP 2535 structure
Common Name ASP 2535
CAS Number 374886-51-8 Molecular Weight 382.418
Density 1.4±0.1 g/cm3 Boiling Point 607.3±65.0 °C at 760 mmHg
Molecular Formula C22H18N6O Melting Point N/A
MSDS N/A Flash Point 321.1±34.3 °C

 Use of ASP 2535


A potent, selective, brain permeable, orally available glycine transporter-1 (GlyT1) inhibitor with IC50 of 92 nM (rat GlyT1), 50-fold selectivity over GlyT2; shows minimal affinity for many other receptors except for μ-opioid receptors (IC50=1.83 uM); inhibits ex vivo [(3)H]-glycine uptake in mouse cortical homogenate, improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease. Schizophrenia Phase 1 Discontinued

 Names

Name 4-[3-Isopropyl-5-(6-phenyl-3-pyridinyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole
Synonym More Synonyms

 ASP 2535 Biological Activity

Description A potent, selective, brain permeable, orally available glycine transporter-1 (GlyT1) inhibitor with IC50 of 92 nM (rat GlyT1), 50-fold selectivity over GlyT2; shows minimal affinity for many other receptors except for μ-opioid receptors (IC50=1.83 uM); inhibits ex vivo [(3)H]-glycine uptake in mouse cortical homogenate, improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease. Schizophrenia Phase 1 Discontinued
References References 1. Harada K, et al. Eur J Pharmacol. 2012 Jun 15;685(1-3):59-69. View Related Products by Target Glycine Transporter (GlyT) Schizophrenia

 Chemical & Physical Properties

Density 1.4±0.1 g/cm3
Boiling Point 607.3±65.0 °C at 760 mmHg
Molecular Formula C22H18N6O
Molecular Weight 382.418
Flash Point 321.1±34.3 °C
Exact Mass 382.154205
LogP 5.09
Vapour Pressure 0.0±1.7 mmHg at 25°C
Index of Refraction 1.717

 Synonyms

2,1,3-Benzoxadiazole, 4-[3-(1-methylethyl)-5-(6-phenyl-3-pyridinyl)-4H-1,2,4-triazol-4-yl]-
4-[3-Isopropyl-5-(6-phenyl-3-pyridinyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole